Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model.

Journal: Neuron

Published: 2019-12-04

DOI: 10.1016/j.neuron.2019.11.007

Affiliations: 9

Authors: 22

Go to article
Institutions Share
Biogen Inc., United States of America (USA) 0.23
Neurimmune Holding AG, Switzerland 0.14
Department of Neurology and Neurosurgery, JHU, United States of America (USA) 0.14
Center for NeuroGenetics (CNG), UF, United States of America (USA) 0.09
Department of Molecular Genetics and Microbiology (MGM), UF, United States of America (USA) 0.09
Genetics Institute (UFGI), UF, United States of America (USA) 0.09
Norman Fixel Institute for Neurological Diseases, UF, United States of America (USA) 0.09
McKnight Brain Institute (MBI), UF, United States of America (USA) 0.09
Institute for Regenerative Medicine (IREM), UZH, Switzerland 0.05

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER